Plague is still endemic in different regions of the world. Current vaccines raise concern for their side effects and limited protection, highlighting the need for an efficacious and rapidly producible vaccine. Fl and V antigens of Yersinia pestis, and Fl-V fusion protein produced in Nicotiana benthamiana administered to guinea pigs resulted in immunity and protection against an aerosol challenge of virulent Y. pestis. We examined the effects of plant-derived Fl, V, and Fl-V on human cells of the innate immunity. Fl, V, and Fl-V proteins engaged TLR2 signalling and activated IL-6 and CXCL-8 production by monocytes, without affecting the expression ofTNF-a, IL-12, IL-IO, IL-l~, and CXCLIO. Native Fl antigen and recombinant plant-derived Fl (rFl) and rFI-V all induced similar specific T-cell responses, as shown by their recognition by T-cells from subjects who recovered from Y.pestis infection. Native Fl and rFl were equally well recognized by serum antibodies of Y.pestis-primed donors, whereas serological reactivity to rFI-V hybrid was lower, and that to rV was virtually absent. In conclusion, plant-derived Fl, V, and FI-V antigens are weakly reactogenic for human monocytes and elicit cellmediated and humoral responses similar to those raised by Y. pestis infection.
in mice challenged with virulent bacteria (3, 6) , and elicits antibody responses in vaccinated humans (3) .
The V antigen, a secreted protein encoded on the 70-kb plasmid pCD l, can suppress the host immunity (7) . Recombinant V (rV) antigen produced in Escherichia coli elicits protection in mice (8) , and passive immunization with anti-V antigen sera protects against subcutaneous challenge (9) . Combined formulation ofFl and V showed levels of protection in mice three times greater than the KWC vaccine (2) . A genetic fusion of the two antigens (Fl-V) used as vaccine also induced high titer, longlasting protective antibodies in animals (4) (5) .
Recently, there has been considerable interest in using transgenic plants to generate recombinant proteins for medical and veterinary use. A variety of molecules have been expressed in plants, including human proteins or viral and bacterial antigens (10) (11) . The use of unique vectors (12) (13) for robust expression of Y. pestis recombinant (r)Fl, rV, and rFl-V fusion proteins in leaves of Nicotiana benthamiana generated Y. pestis antigens that protected guinea pigs against aerosol challenge with Y. pestis at doses 100% lethal to unvaccinated controls (14) .
Here we describe the in vitro effects of plantderived Y. pestis rF 1, rV, and rF 1-V on cells of the human innate and adaptive immunity. Recognition of microbial products by Toll-like receptors (TLR) leads to initiation of adaptive immune responses (15) (16) . We show that p1arit-derived rF 1, rV and rF 1-V are TLR2 agonists, and they significantly increase IL":6 and, to a lesser extent, CXCL-8 production by human monocytes, without affecting TNF-a, IL-12, IL-lO, IL-l p, and CXCLl 0 production. Moreover, rF 1, rV, and rF 1-V are recognized by memory T-cells and by serum antibodies of a number ofpatients who recently recovered from plague. MATERIALS AND METHODS rF1, rV, and rF1-V fusion protein were cloned, expressed and purified from leaves of Nicotiana benthamiana (14) . The FI portion ofrF1-V consists of 150 amino acids followed by two linker amino acids, and the 326 amino acids of the V sequence. rFI-V consists of 478 amino acids with a predicted molecular mass of 53,193 Da, whereas rF I and rV are predicted to weigh 15,694 and 37,240 Da, respectively. ELlSAs for rF1, rV, and rFI-V were performed by using the E. coli recombinant antigens as standards and specific polyclonal antisera (14) . Endotoxin-free preparations were lyophilized until used for both human and animal studies (14) . Purified native F I antigen was prepared as reported (6, 17) . F I antigen purification was carried out by 5 precipitations with a gradient of ammonium sulphate (20 to 30%). Purified F I antigen was lyophilized and stored at -20°e.
PBMC from 16 healthy donors were isolated by centrifugation on Ficoll-Paque. PBMC were laid on Percoll 46% v/v solution (Amersham, Sweden). Monocytes were harvested and further purified by adherence (I h at 37°C) to plastic. Monocytes (CDI4+ cells were >98%) were cultured in RPMI 1640-10% FCS in the absence or presence of graded concentrations (from 0.1 to 10 ug/ml) of rF1, rV, and rF1-Y. After 36 h, supernatants were collected and assayed for TNF-a, IL-12, IL-IO, IL-I~, IL-6, CXCL-8 and CXCLl 0 content by specific ELlSAs (R&D Systems). To evaluate the effects of rF1, rV, and rFI-V on the LPS-induced cytokine production, monocytes were incubated with graded concentrations of rFI, rV and rF1-V for 2 h before addition of LPS (1 Ilg/ ml), and cytokine secretion was assessed in supernatants after an additional 36 h.
Human embryonic kidney (HEK) 293 cells were used for analysis of TLR-dependent activation. NF-KB dependent reporter gene activation was used as read out, as described (18) . Briefly, the analysis of TLR activation was performed on engineered HEK 293 cell lines constitutively expressing one single TLR, as well as pNiFty (an ELAMI reporter gene driven by NF-KB) (InvivoGen, Toulouse, France). Each HEK 293-TLR cell line was induced with rFI, rV, and rF1-V, and a known specific ligand as positive control (18) . Recombinant HEK 293 cell line for the reporter gene only was the negative control. The various NF-KB activation assays were quantified on a luminometer as optical density values (OD) after 24 h stimulation.
PBMC were obtained from 20 subjects (10 males and 10 females) who experienced Y. pestis infection (17 bubonic and 3 pulmonary) and were followed up by the Institute Pasteur of Madagascar. The diagnosis of plague was based on F I antigen detection (19) , and direct culture on selective medium, or after a mouse inoculation of clinical specimens (20) . Three donors were tested within 20-40 days from diagnosis of bubonic plague. Five patients with bubonic plague were tested between 60 and 90 days after diagnosis. Other 6 donors were sampled between 5 and 20 months after diagnosis (5 bubonic and 1 pulmonary), whereas 5 donors were tested between 26 and 41 months from plague (4 bubonic and I pulmonary) and one donor was sampled after 11 years from her pulmonary plague. The 52-year-old mother of a boy who contracted bubonic plague 18 months before testing, asked to be sampled as a healthy exposed individual. PBMC were also obtained from 20 healthy donors never exposed to Y pestis. PBMC were resuspended in RPMI 1640 medium-5% human serum and seeded (2 x 10 5/0.1 ml/microwell) in the presence of medium or graded concentrations (0.1, I and 10 ug/ml) of purified native F I, or rF 1, rV, rF I-V. After 5-day culture, 2 J.lCi [3H]TdR was added to each microwell, and T-cell proliferation was measured as [3H]TdR uptake 20 hours later. When mitogenic index (MI) was> 2, responses were considered as positive.
To assess whether rF I, rV and rF I-V proteins might be recognized by specific antibodies present in the serum of Y pestis-primed subjects, microplates were coated with each one of the recombinant proteins (rF I, rV or rF 1-V) or with native Fl. ELISAs were performed as reported (21). Briefly, each microwell was coated with 50 J.lI antigen (3.3 ug/ml final concentration). After overnight incubation at 4°C, 50 J.lI of a 1/100 dilution of sera were added, followed by anti-human y-chain peroxidase conjugate. The enzymatic activity was determined with ortho-phenylene diamine and HP2 and OD measured at 492 nm. The cut-off value was determined by testing sera from negative controls. A serum with OD > 0.350 was considered as positive.
Results are expressed by means ± SD. Cytokine levels in supernatants of cultures stimulated with medium alone or plant-derived rFI, rV, and rFI-V proteins were compared using the paired Student's t test using Microsoft Excel (Redmond, WA). A p value less than 0.05 was considered to be significant.
RESULTS
After 36 h incubation with medium alone, monocyte cytokine production was low, with the exception of CXCL-8 and IL-6 that were consistently detectable in supernatants from all donors (Table I) . Graded concentrations (0.1 to 10 ug/ml) ofrF1, rV and'rf l-V were added in parallel cultures of monocytes from the same donors and cytokine production was assessed after 36 h. No significant and Consistent change was observed in the levels of secreted TNF-a, IL-12, IL-IO, IL-lP, or CXCLl 0 at any concentration of rF 1, rV or rF I-V tested. In contrast, 10 ug/rnl rF 1, rV or rF I-V resulted in a consistent and significant increase of IL-6 production (p < 0.0001). Such an increase was less significant (p < 0.05) at 1 ug/ml of each protein, but it was undetectable at 0.1 ug/ml, Likewise, 0.1 and 1.0 ug/ml rFl, rV and rFI-V induced no or little increase of CXCL-8, whereas 10 ug/ml of either rF I or rV significantly increased CXCL-8 secretion (p < 0.002). Up-regulation of CXCL-8 induced by 10 ug/ml rFI-V was lower and not significant (p = 0.66) in comparison with paired CXCL-8 values measured in cultures stimulated with medium (Table I) .
Since earlier studies reported that V antigen inhibited the LPS-induced TNF-a and IL-12 expression in murine macrophages (22) (23) , rF1, rV, and rF I-V were tested for their effects on the LPS-induced cytokine production by human monocytes. At any rF 1, rV, and rF I-V concentration, no significant change was observed in the LPSinduced TNF-a and IL-12 secretion, nor in other cytokines measured in this study (data not shown). Likewise, addition of rF 1, rV or rF I-V to the culture did not affect human T-cell proliferation induced by antigen (tetanus toxoid or PPD) or alloantigen stimulation, nor induced proliferation in T-cell derived from donors never exposed to Y p-estis (data not shown). These data suggest that plant-derived rF1, rV and rF1-V are mildly reactogenic in vitro on human monocytes, and do not affect the Ag-induced activation of human T cells.
To define whether a given TLR could interact with plant-derived rF1, rV and rF1-V, we used HEK 293 cells transfected with plasmids encoding distinct human TLRs (18) . Activation was observed only in cells expressing TLR2 (Table II) . Dose-response experiments showed the activation ofNF-KB by rF 1, rV, and rFI-V in a range from 0.1 to 10 ug/ml ( Fig.  1) , which was weaker than that observed with the positive control PAM2.
Twenty subjects who had previously experienced Y pestis infection provided their informed consent to donate 10 ml blood. A cohort of 20 healthy subjects who had never come into contact with Y pestis served as negative controls. PBMC from donors (# 1, # 2, # 3) tested within 40 days from 'diagnosis failed to respond to any of the Y pestis antigens (Fl, rFl, rV, or rF1-V) ( Fig. 2 ). Of the 5 tested between 60-90 days after diagnosis, 3 subjects (# 5, # 6, # 7)
showed T-cell response to F I, rF 1 or rF I-Vat 10 !J,g/ ml, but not to lower antigen dose (data not shown). T-cells from subjects # 6 and # 7 also showed a moderate response to rV antigen. A significant Tcell proliferation was detected in 4 (# 10, # 12, # 13, # 14) out of the 6 donors tested between 5 and , but not to rV, was observed in the healthy donor who had Y. pestis contact 18 months before, when her son (# 13) developed bubonic plague (data not shown). None of the 20 healthy negative controls showed an MI higher than 1.5, even at the highest antigen dose, indicating that the antigen preparations used in our assays were devoid of contaminants with T-cell stimulatory activity or cross-reactivity with antigens of common pathogens. In summary, in a time period between 2 and 20 months from diagnosis, 7 out of II patients who survived plague and one healthy exposed subject had, in their peripheral blood, a number of T cells specific for Y. pestis antigens suitable for detection by proliferation assay. In contrast, no T-cell response was detectable in donors tested within the first month after diagnosis or in the majority (5 out of 6) of donors tested later than 26 months from the disease. Even in the 7 responders to rF I, T-cell proliferation to rV antigen was usually limited. A specific T-cell response to rF 1-V was observed in 9 of the donors and in the healthy exposed contact, showing that the fusion protein structure does not hamper the recognition of the relevant T-cell epitopes.
Sera from negative controls did not react with F I, rFI, rV or FI-V, whereas all 7 samples from donors who experienced Y. pestis infection showed F1specific IgG response. The same sera also reacted to plant-derived rFI with OD slightly higher than those observed with FI at the same serum dilutions (Table  III) . Though the F I sequence was present in rF I-V, the reactivity of anti-FI positive sera to rFI-Vcoated wells was lower than that to rF I, being over the cut-off in only 4 out of 7 seropositive samples (# 5, # 7, # 13, and control E). These data suggest that the rF 1-V structure is not optimal for binding of specific antibodies raised by natural exposure to Y. pestis, or that a number of serological FI epitopes in rF 1-V are not suitable for antibody binding. The contribution of the V antigen to the recognition by specific antibodies was low, as demonstrated by the limited reactivity to rV antigen of sera from donors who contracted Y. pestis infection (Table III) . Such a lack of reactivity to rV antigen was confirmed in a series of other 14 subjects who were anti-Fl seropositive (data not shown).
DISCUSSION
Plague is still an endemic disease in different regions of the world. Discovery of antibioticresistant strains, and concern about Y. pestis as an agent of biological warfare has highlighted the need for a safe, efficacious, and rapidly producible vaccine. Subunit vaccines are the most attractive option, in particular rF I, rV, and rF 1-V, already tested in mice in terms of immunogenicity and protection (6, 9, (24) (25) . Guinea pigs have also been used in protection studies using rF I and rV produced in E. coli (2) . The efficacy of the rF I and rV to elicit immune responses in healthy volunteers in a phase-I trial has been demonstrated (26) . The efficacy of plant-produced rFI, rV, and rFI-V was demonstrated in guinea pigs (14) . Antigens produced in plants retain antigenicity and immunogenicity when tested in different animals and in humans (11, 27-28).
In mice, rV expressed in E. coli inhibited the LPS-induced macrophage production of TNFa, CXCL I0 and IL-12, and treatment of murine macrophages for 2 h with rV resulted in IL-IO expression (22) (23) . In our experiments with human monocytes, rFl, rV and rFl-V failed to affect LPSinduced cytokine production, nor up-regulated IL-10. Likewise, rFl, rV and rFl-V showed no effect on antigen-induced T-cell proliferation, suggesting that human T-cell responses are not hampered by plant-derived rFl, rV or rFI-Y. A concern for using plant-derived rFl, rV and rFI-V as oral vaccines in humans is the activation of pro-inflammatory cytokines in the gut. Being TLR2 agonists, it would not be surprising if administration of rF 1, rV and rF1-V results in a proinflammatory response. However, when tested on normal monocytes, no significant and consistent change was observed in the levels of TNF-a, IL-12, IL-lO, IL-lP, and CXCLlO, at any of the concentrations ofrFl, rVand rF 1-V tested. Rather, the addition of 10 ug/ml rF 1, rV or rF 1-V resulted in a consistent and significant increase of IL-6 production, but such an increase was poor or moderate at 0.1 ug/ml or 1 ug/rnl of each protein. Likewise, low dose rF 1, rV and rF I-V induced no or little increase of CXCL-8, whereas 10 ug/ml of either rF 1 or rV significantly increased CXCL-8 secretion. Interestingly, up-regulation of CXCL-8 induced byrf l-V was lower and not significant (p = 0.66) in comparison with CXCL-8 values in supernatants of monocytes stimulated with medium alone. The effects of rF I-Von the cytokine production by human monocytes fully overlapped those induced by the two components of the hybrid. The data suggest that plant-derived rF 1, rV and rF 1-V are poorly reactogenic on human monocytes. Recent data indicate that human secondary lymphoid tissue contains long-lived IgA and IgG secreting plasma cells that depend on IL-6 and intact microenvironment architecture for survival and Ig secretion (29) . On the other hand, IL-6, in combination with TGF-J3, is required for initiation of the differentiation of ThI7 cells, a distinct CD4+ T-cell lineage, whose role in autoimmunity and chronic inflammatory bowel diseases is still matter of investigation. The V-antigen (LcrV) was described as the major virulence marker of Y. pestis (30) . In mice, V antigen is an immunomodulator (TNF-u and IFN-y down- regulation and IL-IO induction) both in vivo and in vitro (31) (32) . Such effects would depend on TLR2 stimulation (33) . Evidence of the interaction of V antigen with human TLR2 has been provided (34) (35) . Overheim et al. (35) showed that LcrV derived from Y. pestis and purified fromE. coli induced IL-I 0 from murine macrophages and human monocytes. It also suppressed induction of TNF from murine macrophages. However, experiments with highly purified V molecule indicated that only a very high-molecular-weight multimer or aggregate had stimulatory activity (33) . In our study, the agonistic interaction of rV with TLR2 was further confirmed. Also rFI and rFI-V were TLR2 agonists in the same range of relatively high protein concentration required for V protein. Although rV was slightly more reactogenic on human monocytes than rFI, no up-regulation of IL-l 0, nor down-regulation of pro-inflammatory cytokines were detected. Whether the lack ofrV-induced IL-IO increase depends on the source of responder cells (murine vs human) or on recombinant V proteins (bacterial vs plant), remains unclear. If high-molecular-weight multimer of V protein is required for efficient IL-IO stimulation (34) , it is possible that plant-derived rFI, rV and rF I-V fail to assemble multimers or aggregates and therefore fail to efficiently stimulate IL-IO. In any case, the lack of IL-I 0 induction in human cells by plant-derived rV and rFI-V represents a positive feature of these candidates for oral vaccination.
Plant-derived rFI, rV and rFI-V are recognized by T cells from Y. pestis-primed individuals. In the three subjects tested within 20-40 days from disease, no proliferation of T cells was detectable, though they had already converted to seropositive for anti-FI antibodies. Likewise, apart from one donor who showed a poor T-cell response to FI, rFI and rF I-V, but not to rV antigen, other 5 donors tested after 26 months or more from diagnosis showed no proliferation of their circulating T cells to native or recombinant Y. pestis antigens. Of another 11 Y. pestis-primed donors tested between 2 and 20 months from diagnosis, 7 showed T-cell proliferation to either native F I or rF1 and rF1-V at the highest concentration (10 ug/ml). In 6 of these 11 donors, Tcell proliferation to rV antigen was also detectable, though lower than to native F 1, rF1 or rF I-V. A significant T-cell proliferation to native Fl, rFI, and rF 1-V, but not to rV antigen, was observed also in the healthy exposed donor. These data suggest that in the peripheral blood ofsubjects who experienced plague, the proportion ofT cells specific for native F 1 or rF1, rV, and rF1-V was quite low, and needed at least one month to become detectable in proliferation assays. The need of relatively high antigen concentration to achieve significant mitogenic indexes argues in favor of this explanation. Data also suggest that in Y. pestis-primed donors, the presence of circulating Y. pestis antigen-specific T cells is relatively shortterm, vanishing after 2 years. Since the analysis of responsiveness by T cells derived from other sources, such as lymph nodes, was not feasible, the question of why T-cell memory for Y.pestis antigens is short-lasting in comparison to that against other pathogens remains unclear. T-cell responsiveness to V antigen was never dissociated from that against F 1, but T-cell proliferation to V was consistently lower than to F I. The simplest explanation is that during Y. pestis infection, priming of T-cell response to V antigen was less powerful than to Fl. This would have resulted in lower proportions of recirculating V-specific memory T cells and hence lower in vitro proliferative responses. Since many pathogens evade the host immune response by variation of surface antigens, it is possible that, as observed for Y. enterocolitica. (36) , V antigen polymorphism of Y. pestis bacteria that had infected our donors might account for their relatively poor T-cell and antibody reactivity to plant-derived rV ELISA with native FI or rFI showed anti-Fl IgG antibodies in Y. pestis-primed individuals. As for Tcell response, antibody response to F1 was detectable in subjects tested within 20 months from the disease, vanishing thereafter. In the same sera, reactivity to rFI was slightly, but consistently, higher than to native F1, suggesting that rF1 is suitable for diagnostic procedures. In comparison with rF1, rF1-V was not equally well recognized by sera of Y. pestis-primed subjects. The lower efficiency of rFI-V for antibody binding may be due to poor recognition of its V portion and to the reduction ofB-cell epitopes in the F1 portion due to the fusion protein conformation.
Y. pestis rF1, rV and rF1-V generated in N benthamiana show a number of positive features: i) poor reactogenicity on human innate immunity without induction of pro-inflammatory cytokines nor of IL-10, ii) low CXCL-8 up-regulation, iii) induction of IL-6, a promise of prolonged antibody response, and iv) interaction with T-cell receptor of specific T cells similar to the short-term memory T-cells from Y. pestis-primed individuals. These aspects, together with the possibility to elicit antibody responses resembling those of Y. pestis-infected subjects, the high protection of guinea pigs from the pulmonary disease (14) , and demonstration of oral immunogenicity of tomatoderived rFl V (37) suggest a strong potential for these plant-derived antigens as oral vaccine for the prevention ofplague.
